Vertical integration in the OEM business is often described in terms of machinery, processes and internal capacity. That view is too narrow. What matters is not the number of manufacturing steps performed in-house, but the ability to manage material, precision processing, quality, validation, packaging and documentation as one controlled value chain.
A simple product — a complex value chain
Consider a product that appears comparatively simple: a surgical saw blade. For the user, it is a precision instrument that must perform — reliably, reproducibly and to the same standard of quality every time.
Behind that product, however, lies a complex value chain: material selection, precision machining, surface finishing, cleaning, quality inspection, packaging, sterilization and technical documentation. In addition, there are validations, process approvals and regulatory requirements — followed by the task of supplying the product consistently in serial production for many years.
Every single step influences the product’s performance. And every additional interface increases complexity.
Vertical integration means taking responsibility
This is precisely why vertical integration means much more to me today than simply asking how many processes a company can perform in-house. It is about the ability to take responsibility across the entire value chain.
For an OEM, that is a crucial difference. A partner capable of connecting development, engineering, manufacturing, quality and regulatory expertise does more than reduce interfaces. It can bring decisions together faster, identify technical dependencies earlier and manage changes more effectively throughout the entire product lifecycle.
The value becomes visible across the product lifecycle
This becomes particularly relevant when MedTech projects grow demanding in practice. During a New Product Introduction, for example, product design, manufacturability, validation and regulatory requirements must be considered together from the very beginning.
In a later change project, materials, processes or supply chains may need to be modified. Capacity may have to be expanded, second sources established or regulatory requirements adapted.
The value of an integrated partner therefore often becomes evident not only at the successful start of production, but years later — when changes must be implemented quickly, under control and in full regulatory compliance without putting market supply at risk.
What OEMs are really buying
From my perspective, OEMs are not buying vertical integration itself. They are buying something else: less complexity, fewer interfaces, lower risk and greater reliability.
This requires vertical integration not to be treated as an end in itself. Not every company needs to master every process internally. What matters is connecting the critical capabilities of a medical device so that development, industrialization and serial production function as one integrated system.
The changing role of the CDMO
This is also where I see the role of the CDMO changing: from a pure manufacturing partner to an organization that assumes responsibility for a substantial part of the product lifecycle.
For me, this is one of the most exciting developments in the MedTech OEM business. In the end, it is not the individual machine, technology or manufacturing stage that makes the difference. It is the ability to integrate capabilities so that an idea reliably becomes a market-ready medical device — and so that the same product can still be manufactured safely, economically and reproducibly five, ten or more years later.
OEMs do not buy vertical integration. They buy less complexity, fewer interfaces, lower risk and greater reliability across the entire product lifecycle.